la diagnosi clinica delle cardiopatie congenite nel primo anno di vita

2005

QT interval in a population of normal newborns:an epidemiologic study

2004

le cardiopatie congenite in epoca postnatale approccio diagnostico

2004

le cardiopatie congenite nel primo anno di vita

2005

Epidemiology of jaundice in a neonatology ward

2004

Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial

2014

A limited number of nondigestible oligosaccharides are available for use in infant formula. This study evaluated growth and safety in infants fed formula supplemented with a mixture of bovine milk-derived oligosaccharides (BMOS). This mixture, which was generated from whey permeate, contains galactooligosaccharides and other oligosaccharides from bovine milk, such as 3′- and 6′-sialyllactose. We hypothesized that growth in infants fed BMOS-supplemented formula would be noninferior to that in infants fed standard formula. Healthy term infants ≤14 days old were randomly assigned to standard formula (control; n = 84); standard formula with BMOS (IF-BMOS; n = 99); or standard formula with BMOS …

Hypercalciuria and kidney calcifications in terminal 4q deletion syndrome: Further evidence for a putative gene on 4q

2003

We report a newborn girl with a de novo terminal 4q deletion (q31.3 → qter) and a characteristic phenotype of minor facial anomalies, cleft palate, congenital heart defect, abnormalities of hands and feet, and postnatal onset of growth deficiency. Laboratory studies showed excessive urinary calcium excretion on standard milk formula and on oral calcium load. Blood measurements of parathyroid hormone, calcitonin, bicarbonate, calcium, phosphorus, magnesium, sodium, chlorine, potassium, and urinary measurements of phosphorus, magnesium, sodium, chlorine, potassium were normal for age. At 2 months of life, ultrasonography showed kidney calcifications. Clinical and laboratory data support the d…

Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus

1989

Anti-single-stranded–DNA antibodies cross-reactive with heparan sulfate were detected in serums of patients with type I (insulin-dependent) diabetes mellitus. The results suggested that heparan sulfate, the major glycosaminoglycan constituent of the glomerular basement membrane, may serve as a target antigen in vivo for cross-reactive anti-DNA antibodies. These polyreactive antibodies, directed toward repeating negatively charged units, may neutralize the heparan sulfate–associated polyanionic sites in the glomerulus, leading to an abnormal permeability of anionic plasma proteins.

QT interval in a population of healthy neonates:a prospective study

2006

Le cardiopatie congenite nella sindrome di Down: contributo clinico

2005

tachicardia fetale e neonatale in neuroblastoma congenito

2005

emergenze cardiologiche neonatali:le cardiopatie con circolo polmonare dotto dipendente

2006

Modalità del parto e allattamento al seno:studio prospettico

2006

Comunicazione ventricolo sinistro-atrio destro (difetto di Gerbode) in età neonatale

2006

Diagnosi prenatale di emangioma pericardico con evoluzione in idrope fetale

2004

Aritmie potenzialmente letali ad evoluzione favorevole in neonati sani”.

2005

368 Growth of Infant Fed Starter Formula Containing Prebiotics or Symbiotic

2010

Objective: To assess growth of infants fed starter formula supplemented with either prebiotics or symbiotic. In addition, gut microbiota was studied. Methods: Healthy, full term newborns (n= 240) were enrolled before the 14th day of their life and randomly assigned between 3 exclusively formula fed groups: starter IF, starter IF + prebiotics (CMOS+GOS), starter IF + prebiotics (CMOS+GOS) and probiotics (BL999 + LPR). Growth was assessed by body weight gain during 4 months. Gut microbiota profile was examined by measuring fecal counts in Bifidobacteria, Lactobacilli, Enterobacteria, Clostridium at 2 months of age. Incidence of morbidity was appraised. Results: Non inferiority in growth was e…

allattamento al seno in una unità di neonatologia:verifica epidemiologica e strategie di promozione

2005

Clinica evaluation of a new starter formula for infants containing live Bifidobacterium Longun BL999 and prebiotics

2007

Mode of delivery and neonatal short term outcome:a retrospective study

2006

growth of infants fed a starter formula containing bifidobacterium longum BL999 and a mixture of prebiotics

2006

soffio cardiaco:quando consigliare la consulenza cardiologica

2006

Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics.

2006

Abstract Objectives The larger number of bifidobacteria in the intestine of breast-fed infants has been associated with their better health compared with formula-fed infants. We assessed the safety and tolerability of an experimental formula containing 2 × 10 7 colony-forming units of Bifidobacterium longum BL999 and 4 g/L of a prebiotic mixture containing 90% galacto-oligosaccharides and 10% fructo-oligosaccharides. Methods A 7-mo prospective, randomized, reference-controlled, double-blinded trial was performed in infants who were not breast fed after the 14th day of birth. One hundred thirty-eight infants were enrolled and assigned to receive the control or experimental formula until they…